Myovant Sciences Alpha and Beta Analysis
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Myovant Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Myovant Sciences over a specified time horizon. Remember, high Myovant Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Myovant Sciences' market risk premium analysis include:
Beta 0.0247 | Alpha (0.01) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Myovant |
Myovant Sciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Myovant Sciences market risk premium is the additional return an investor will receive from holding Myovant Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Myovant Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Myovant Sciences' performance over market.| α | -0.0074 | β | 0.02 |
Myovant Sciences Fundamentals Vs Peers
Comparing Myovant Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Myovant Sciences' direct or indirect competition across all of the common fundamentals between Myovant Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Myovant Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Myovant Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Myovant Sciences to competition |
| Fundamentals | Myovant Sciences | Peer Average |
| Return On Asset | -0.18 | -0.14 |
| Profit Margin | (0.48) % | (1.27) % |
| Operating Margin | (0.39) % | (5.51) % |
| Current Valuation | 2.6 B | 16.62 B |
| Shares Outstanding | 97.26 M | 571.82 M |
| Shares Owned By Insiders | 48.61 % | 10.09 % |
| Shares Owned By Institutions | 56.21 % | 39.21 % |
Myovant Sciences Opportunities
Myovant Sciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Myovant Sciences earnings missed by 0.14, revenue fell short of estimates | 01/27/2023 |
2 | Janus Henderson Group Cuts Stake in Myovant Sciences - Nasdaq | 02/09/2023 |
3 | Reply to A. Abner et al Journal of Clinical Oncology - ASCO Journals | 03/01/2023 |
4 | Acquisition or disposition of Myovant Sciences securities by Sumitomo Chemical Co Ltd | 03/06/2023 |
About Myovant Sciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Myovant or other delisted stocks. Alpha measures the amount that position in Myovant Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Myovant Sciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Myovant Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Myovant Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Myovant Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Myovant Sciences. Please utilize our Beneish M Score to check the likelihood of Myovant Sciences' management manipulating its earnings.
| 9th of May 2023 Upcoming Quarterly Report | View | |
| 26th of July 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 9th of May 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 31st of March 2022 Last Financial Announcement | View |
Build Portfolio with Myovant Sciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |